Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (39)
COVID-19 (12)
Type
Type
Guidance (1898)
NICE advice (321)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (225)
COVID-19 rapid guidelines (3)
Diagnostics guidance (50)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (603)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (341)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (791)
Advice programme
Advice programme
Evidence summaries (68)
Medtech innovation briefings (253)
Apply filters
Showing 101 to 150 of 2417
Sort by
Date
Title
Apply sorting
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Dupilumab for treating moderate to severe prurigo nodularis
TA955
13 March 2024
13 March 2024
Etrasimod for treating moderately to severely active ulcerative colitis in people aged 16 and over
TA956
11 March 2024
11 March 2024
Lung cancer: diagnosis and management
NG122
28 March 2019
8 March 2024
Vitamin B12 deficiency in over 16s: diagnosis and management
NG239
6 March 2024
6 March 2024
Epcoritamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments
TA954
6 March 2024
6 March 2024
Digital technologies for delivering multidisciplinary weight-management services: early value assessment
HTE14
26 October 2023
6 March 2024
Digital technologies for managing non-specific low back pain: early value assessment
HTE16
5 March 2024
5 March 2024
Endoscopic sleeve gastroplasty for obesity
IPG783
22 February 2024
22 February 2024
Talazoparib for treating HER2-negative advanced breast cancer with germline BRCA mutations
TA952
21 February 2024
21 February 2024
Tuberculosis
NG33
13 January 2016
16 February 2024
Digitally enabled therapies for adults with depression: early value assessment
HTE8
16 May 2023
12 February 2024
Belumosudil for treating chronic graft-versus-host disease after 2 or more systemic treatments in people 12 years and over
TA949
7 February 2024
7 February 2024
Nivolumab–relatlimab for untreated unresectable or metastatic melanoma in people 12 years and over
TA950
7 February 2024
7 February 2024
Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer
TA951
7 February 2024
7 February 2024
Loncastuximab tesirine for treating relapsed or refractory diffuse large B-cell lymphoma and high-grade B-cell lymphoma after 2 or more systemic treatments
TA947
31 January 2024
31 January 2024
Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments
TA948
31 January 2024
31 January 2024
Treosulfan with fludarabine before allogeneic stem cell transplant for people aged 1 month to 17 years with non-malignant diseases (terminated appraisal)
TA945
30 January 2024
30 January 2024
Caesarean birth
NG192
31 March 2021
30 January 2024
Devices for remote monitoring of Parkinson's disease
DG51
25 January 2023
25 January 2024
COVID-19 rapid guideline: managing the long-term effects of COVID-19
NG188
18 December 2020
25 January 2024
Skin cancer
QS130
21 September 2016
24 January 2024
Pharyngeal electrical stimulation for neurogenic dysphagia
IPG781
23 January 2024
23 January 2024
Temperature control to improve neurological outcomes after cardiac arrest
IPG782
23 January 2024
23 January 2024
Neonatal infection
QS75
18 December 2014
23 January 2024
Olaparib with bevacizumab for maintenance treatment of advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer
TA946
17 January 2024
17 January 2024
Early and locally advanced breast cancer: diagnosis and management
NG101
18 July 2018
16 January 2024
Durvalumab with gemcitabine and cisplatin for treating unresectable or advanced biliary tract cancer
TA944
10 January 2024
10 January 2024
Sebelipase alfa for treating Wolman disease
HST30
10 January 2024
10 January 2024
Intravascular lithotripsy for calcified arteries in peripheral arterial disease
IPG780
3 January 2024
3 January 2024
Bipolar disorder: assessment and management
CG185
24 September 2014
21 December 2023
Targeted-release budesonide for treating primary IgA nephropathy
TA937
20 December 2023
20 December 2023
Ravulizumab for treating generalised myasthenia gravis (terminated appraisal)
TA940
20 December 2023
20 December 2023
Ravulizumab for treating AQP4 antibody-positive neuromyelitis optica spectrum disorder (terminated appraisal)
TA941
20 December 2023
20 December 2023
Empagliflozin for treating chronic kidney disease
TA942
20 December 2023
20 December 2023
Epilepsies in children, young people and adults
QS211
20 December 2023
20 December 2023
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes
TA943
19 December 2023
19 December 2023
Risdiplam for treating spinal muscular atrophy
TA755
16 December 2021
15 December 2023
Digitally enabled therapies for adults with anxiety disorders: early value assessment
HTE9
16 May 2023
14 December 2023
Middle meningeal artery embolisation for chronic subdural haematomas
IPG779
14 December 2023
14 December 2023
Cardiovascular disease: risk assessment and reduction, including lipid modification
NG238
14 December 2023
14 December 2023
Transition from children's to adults' services
QS140
21 December 2016
14 December 2023
Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer
TA939
13 December 2023
13 December 2023
Velmanase alfa for treating alpha-mannosidosis
HST29
13 December 2023
13 December 2023
Dupilumab for treating eosinophilic oesophagitis in people 12 years and over (terminated appraisal)
TA938
7 December 2023
7 December 2023
Acne vulgaris: management
NG198
25 June 2021
7 December 2023
Secukinumab for treating moderate to severe hidradenitis suppurativa
TA935
6 December 2023
6 December 2023
Idecabtagene vicleucel for treating relapsed and refractory multiple myeloma after 3 or more treatments (terminated appraisal)
TA936
30 November 2023
30 November 2023
Tisagenlecleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic therapies (terminated appraisal)
TA933
29 November 2023
29 November 2023
Foslevodopa–foscarbidopa for treating advanced Parkinson's with motor symptoms
TA934
29 November 2023
29 November 2023
Percutaneous thrombectomy for intermediate-risk or high-risk pulmonary embolism
IPG778
29 November 2023
29 November 2023
Previous page
1
2
Current page
3
4
5
…
49
Page
3
of
49
Next page
Results per page
10
25
50
All
Back to top